Marco Marzioni Selected Research

Marco Marzioni Research Topics

Disease

27	Cholestasis 10/2022 - 05/2002
22	Fibrosis (Cirrhosis) 01/2022 - 02/2003
16	Neoplasms (Cancer) 01/2022 - 12/2005
16	Cholangiocarcinoma 01/2022 - 12/2005
14	Liver Diseases (Liver Disease) 01/2022 - 11/2002
11	Sclerosing Cholangitis 01/2022 - 04/2013
8	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2022 - 12/2008
6	Inflammation (Inflammations) 10/2022 - 10/2004
5	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019 - 11/2002
4	Non-alcoholic Fatty Liver Disease 01/2017 - 09/2006
3	Disease Progression 01/2022 - 01/2017
3	Polycystic liver disease 01/2021 - 10/2015
3	Necrosis 01/2017 - 10/2004
3	Hyperplasia 10/2014 - 05/2007
2	Obesity 01/2022 - 09/2006
2	Autoimmune Diseases (Autoimmune Disease) 04/2021 - 08/2017
2	Infections 01/2017 - 11/2007
2	Polycystic Kidney Diseases (Polycystic Kidney Disease) 01/2017 - 10/2014
2	Dysbiosis 01/2017 - 05/2014
2	Pancreatic Neoplasms (Pancreatic Cancer) 02/2015 - 10/2007
2	Insulin Resistance 01/2014 - 09/2006
1	Choledocholithiasis 01/2022
1	Hepatitis 01/2022
1	Overweight 01/2022
1	Cholelithiasis 12/2020
1	progressive familial intrahepatic 1 Cholestasis 12/2020
1	Intrahepatic Cholestasis of Pregnancy 12/2020
1	Hypertriglyceridemia 12/2020
1	Cholangitis 01/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020
1	Carcinoma (Carcinomatosis) 01/2019
1	Pathologic Processes 01/2019
1	Hepatoblastoma 01/2019
1	Liver Neoplasms (Liver Cancer) 01/2019

Drug/Important Bio-Agent (IBA)

10	Bile Acids and Salts (Bile Acids)IBA 01/2018 - 05/2002
8	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2007
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
6	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 01/2022 - 10/2015
6	Messenger RNA (mRNA)IBA 01/2020 - 05/2006
6	Secretin FDA Link 01/2019 - 04/2003
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2018 - 12/2005
5	Hormones (Hormone)IBA 02/2009 - 06/2006
3	Pharmaceutical PreparationsIBA 04/2021 - 11/2002
3	secretin receptorIBA 01/2019 - 01/2016
3	Bicarbonates (Hydrogen Carbonate)IBA 01/2019 - 11/2004
3	Ribavirin (Virazole)FDA LinkGeneric 10/2018 - 01/2014
3	Alkaline PhosphataseIBA 01/2018 - 01/2017
3	EnzymesIBA 01/2016 - 11/2008
3	CollagenIBA 10/2014 - 12/2005
3	NeuropeptidesIBA 08/2011 - 07/2008
3	Serotonin (5 Hydroxytryptamine)IBA 05/2010 - 01/2005
3	Biological ProductsIBA 07/2007 - 01/2007
2	BilirubinIBA 01/2020 - 08/2011
2	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2020
2	MicroRNAs (MicroRNA)IBA 01/2019 - 11/2018
2	paritaprevirIBA 10/2018 - 01/2017
2	dasabuvirIBA 10/2018 - 01/2017
2	ombitasvirIBA 10/2018 - 01/2017
2	Ritonavir (Norvir)FDA Link 10/2018 - 01/2017
2	CytokinesIBA 01/2018 - 07/2003
2	3,5- diethoxycarbonyl- 1,4- dihydrocollidineIBA 02/2017 - 10/2014
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2017 - 09/2006
2	1-dodecylpyridoxal (PLD)IBA 01/2017 - 10/2015
2	Thioacetamide (Thioacetamid)IBA 02/2012 - 08/2008
2	Vascular Endothelial Growth Factor CIBA 08/2009 - 12/2005
2	Mitogen-Activated Protein Kinase 3IBA 08/2008 - 12/2005
2	Adrenergic Agents (Adrenergic Drugs)IBA 10/2007 - 05/2007
2	Neurotransmitter Agents (Neurotransmitter)IBA 05/2007 - 12/2005
2	Opioid Peptides (Opioid Peptide)IBA 04/2007 - 05/2006
2	Inositol (Myoinositol)IBA 04/2006 - 12/2005
1	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2022
1	NanogelsIBA 01/2022
1	Hyaluronic Acid (Hyaluronan)IBA 01/2022
1	6-propylchromone-2-carboxylic acid (PCCA)IBA 01/2022
1	Budesonide (Pulmicort)FDA LinkGeneric 01/2022
1	Therapeutic UsesIBA 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 04/2021
1	SuspensionsIBA 04/2021
1	obeticholic acidIBA 04/2021
1	TransferasesIBA 01/2021
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2021
1	S-Adenosylmethionine (Ademetionine)IBA 01/2021
1	Phospholipids (Phosphatides)FDA LinkGeneric 12/2020
1	Liver X ReceptorsIBA 12/2020
1	Adenosine Triphosphate (ATP)IBA 12/2020
1	Oral ContraceptivesIBA 12/2020
1	Mannose ReceptorIBA 01/2020
1	IntegrinsIBA 01/2020
1	vedolizumabIBA 01/2020
1	CateninsIBA 01/2019

Therapy/Procedure

14	Therapeutics 01/2022 - 11/2002
10	Ligation 10/2022 - 10/2003
4	Liver Transplantation 01/2021 - 01/2017
3	Drug Therapy (Chemotherapy) 01/2020 - 11/2008
2	Radiotherapy 05/2010 - 11/2008
2	Denervation 10/2007 - 05/2007
1	Aftercare (After-Treatment) 06/2021
1	Transplantation 01/2020